In Depth 22 May 2024
The undruggable cancer target: KRAS inhibitors move ahead in the clinic
Uncover the promise of KRAS inhibitors in cancer treatment, as evidenced by a $200 million investment in BridgeBio’s spinout.
Cancer
- Latest Posts
Best in Biotech 21 May 2024
Eight companies spearheading Philadelphia’s biotech industry
Often called the Cellicon Valley due to its focus on cell and gene therapy, discover eight Philadelphia biotech companies to know about.
Cell avidity-tuning ensures safe CAR-T therapy for solid tumors
Learn more about the potential of cell avidity in designing potent and safe CAR-T treatments for solid tumors.
In Depth 9 May 2024
BTK inhibitors: can these drugs tackle cancer and autoimmunity?
BTK inhibitors were first approved over a decade ago to treat a rare blood cancer. Now, they are in the running to treat a host of autoimmune diseases.
Best in Biotech 2 May 2024
Eight monoclonal antibody biotechs making strides in the clinic
In this article, we take a look at eight biotechs advancing their monoclonal antibodies through the clinic that have made the news in recent times.
In Depth 24 Apr 2024
Overcoming toxicities: are IL-2 smart cytokines the next big thing?
A more advanced form of IL-2 cytokine therapy called IL-2 smart cytokines could overcome side effects, and shake up cancer care as we know it.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 23 Apr 2024
Eight biotechnology companies leading the charge in Poland
Discover eight biotech companies at the forefront of Poland’s emerging biotech sector, which is becoming a hotspot for startups.
Best in Biotech 16 Apr 2024
Seven biotech companies climbing their way up in Colorado
We take a look at seven biotechs in Colorado that have secured funding in recent years, to make headway with their pipeline candidates.
In Depth 10 Apr 2024
Silencing genes to cure diseases: an in-depth look at siRNA
Delve into the promissing and dynamic sector of siRNA technology, with new drug approvals and advancements in delivery methods.
In Depth 4 Apr 2024
Seven diseases CRISPR technology could cure
Here are some of the diseases that scientists aim to tackle using CRISPR technology, testing its possibilities and limits as a medical tool.
Best in Biotech 28 Mar 2024
Are these T cell receptor (TCR) therapy companies on your radar?
As biotechs step up in the TCR therapy space, here are seven companies with promising candidates in the clinic.
Best in Biotech 21 Mar 2024
Eight CAR-T cell therapy companies you should know about
Discover eight promising biotech companies that are advancing their CAR T cell therapy candidates in the clinic.
ADVERTISEMENT
